FDA Inspection
Nordmark Arzneimittel GMBH & Co. KGNordmark Arzneimittel GMBH & Co. KG – FDA Inspection, Feb 13, 2025
Record Details
This FDA Inspection record concerns Nordmark Arzneimittel GMBH & Co. KG, with an inspection on February 13, 2025, issued by the Office of Inspections and Investigations, covering human drugs.
View Company Profile
ID · 2deb9c88-7f3a-400e-8a1f-9888c509eb7b
Inspection Facts
- Inspection number
- 1263912
- FDA center
- Human Drugs
Other FDA inspections of Nordmark Arzneimittel GMBH & Co. KG
7| Date | Classification | Office | Project area |
|---|---|---|---|
| August 31, 2023 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| August 16, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 17, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 20, 2014 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| November 29, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Nordmark Arzneimittel GMBH & Co. KG
- FDA Inspection 1241654 - 2023-08-31
- FDA Inspection 1099709 - 2019-08-16
- FDA Inspection 1006686 - 2017-02-17
- FDA Inspection 907095 - 2014-11-20
- FDA Inspection 810090 - 2012-11-29
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.